JARRETT KACZMARSKI: Open Payments
NPI 1740362516 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,051 in 293 payments from 24 companies in 2025. Trend: 2023 $3,057 · 2024 $3,823 · 2025 $5,051
Food & beverage: $5,051
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $832 |
| Incyte Corporation | 31 | $552 |
| ABBVIE INC. | 33 | $455 |
| Novartis Pharmaceuticals Corporation | 28 | $395 |
| Amgen Inc. | 15 | $332 |
| E.R. Squibb & Sons, L.L.C. | 20 | $313 |
| Galderma Laboratories, L.P. | 16 | $285 |
| GENZYME CORPORATION | 9 | $253 |
| Lilly USA, LLC | 14 | $223 |
| UCB, Inc. | 13 | $207 |
Products named: OPZELURA, ADBRY, DUPIXENT, ANZUPGO, Sotyktu, SKYRIZI, NEMLUVIO, COSENTYX.
Industry payments across NY — which companies pay providers there.
